| | | Contact | Search:
DROGSAN      QUALITY POLICY      PRODUCT PORTFOLIO      CONTACT     
Drogsan Pharmaceuticals

With its own in-house R&D, Production, Warehousing, Distribution, Sales / Marketing and Export facilities, Drogsan serves the world pharmaceutical industry with the global goal of a healthier future. Driven by the internal force of its vision of being a research based, value added international pharmaceutical company, Drogsan is dedicated to provide healthcare professionals with innovative quality solutions.

Details...
Latest News

  • Drogsan to attend EuroPLX 49 Istanbul, June 2012.
  • Lapilori 30 mg Micropellet Capsule, Fusinat 500 mg Film Tablet, and Zincobest 15 mg/5 ml Syrup launched in Turkish market, March 2012.
  • Drogsan manufacturing site EU GMP audit took place in December 2011.
  • Kloroben Oral Spray, Mometix AQ Nasal Spray, and Dalman AQ Nasal Spray obtained marketing authorisation in Cambodia , 4Q2011.
  • Clopra 75 mg Film Tablet launched in Hong Kong and Malaysian markets, September 2011.
  • Drogsan manufacturing site has been approved by Gulf Central Registration Committee, February 2011.




Drogsan Plant Tour
All Rights Reserved. © Drogsan Pharmaceuticals
Oğuzlar Mh. 1370. Sk. No:7/3 06520 Balgat, ANKARA-TURKEY • Tel : +90 312 287 74 10 - Fax: +90 312 287 61 15 • E-mail: business.development@drogsan.com.tr
Information contained in this site do not substitute for consulting a healthcare professional.